Compass Therapeutics, Inc.CMPXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+13.1%
5Y CAGR+5.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+13.1%/yr
vs +1.0%/yr prior
5Y CAGR
+5.5%/yr
Recent acceleration
Acceleration
+12.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.87M | +11.5% |
| 2024 | $15.13M | +23.6% |
| 2023 | $12.24M | +5.0% |
| 2022 | $11.66M | +6.7% |
| 2021 | $10.93M | -15.3% |
| 2020 | $12.91M | +11.2% |
| 2019 | $11.60M | +3.4% |
| 2018 | $11.22M | - |